The thing about sun spots that changes your approach to everything is this: your skin is not trying to clear them.
Post-inflammatory marks are actively fading because the body treats them as temporary. The pigment was deposited in response to a single event, and once that event is over, the normal turnover process gradually pushes it out. Sun spots do not work that way. They are the result of cumulative UV damage that has permanently altered melanocyte behaviour in those specific areas. The cells themselves have changed. They are producing excess melanin as a new default, not as a temporary stress response.
That distinction is the reason sun spots do not budge on their own, the reason waiting for them to fade is not a strategy, and the reason the treatment approach looks fundamentally different from what works for PIH or melasma.
What they look like
Sun spots appear as flat, well-defined brown marks. The edges are typically sharper and more distinct than melasma (which has diffuse, blending borders) and comparable to or slightly softer than PIH marks.
The colour is usually a consistent medium to dark brown within each individual spot, though it can vary between spots on the same person depending on how much UV exposure that area has accumulated. Sun spots do not typically show the blue-grey tones associated with deep dermal pigment in PIH or melasma.
Size ranges from a few millimetres to over a centimetre. They tend to be larger than freckles and more irregular in shape. Where freckles are small, uniform dots, sun spots have more variable outlines that reflect the uneven pattern of cumulative UV damage at the cellular level.
The surface is flat. There should be no raised texture, roughness, or scaliness. If a brown mark is raised, rough to the touch, or has a scaly surface, it may be a seborrhoeic keratosis (a benign growth) or an actinic keratosis (a precancerous lesion), both of which require different evaluation. Flat and smooth is the sun spot profile.
Where they appear
Sun spots appear on areas of the skin that have received the most cumulative UV exposure over a lifetime. The distribution tells the story of decades of sun contact.
The most common locations are the face (particularly the cheeks, temples, and forehead), the backs of the hands, the forearms, the chest, and the shoulders. These are the areas that are exposed most consistently over the years, even in people who use sun protection intermittently.
The distribution is not symmetrical in the way melasma is. Sun spots are scattered and independent. Each one reflects a localised area of UV-altered melanocyte activity. You might have several on one cheek and none on the other, a cluster on one hand and a single mark on the other. The randomness of the distribution reflects the randomness of UV exposure patterns over years.
Location is a useful but not definitive identification marker. PIH and melasma can also appear on sun-exposed areas of the face, which is why trigger history and behaviour matter more than location alone.
What causes them
Sun spots are the product of cumulative UV exposure over years and decades. There is no single triggering event. No sunburn that you can point to. No moment when the spot appeared. Instead, the damage accumulates gradually until a threshold is crossed and the melanocytes in that area begin overproducing as their new steady state.
The mechanism works like this: repeated UV exposure causes progressive DNA damage in melanocytes and the surrounding keratinocytes. Over time, this damage alters the gene expression of those melanocytes, upregulating their pigment production and changing their behaviour permanently. The result is a localised cluster of melanocytes that produce more melanin than the surrounding skin, creating a visible spot.
This is why sun spots tend to appear in the 30s, 40s, and beyond. They are not an acute response to a recent event. They are the visible accumulation of a lifetime of UV exposure reaching the point where the cellular changes become apparent. People with more cumulative UV exposure, lighter skin tones (which provide less natural UV filtering), or a genetic predisposition to solar damage tend to develop them earlier and in greater numbers.
UVA radiation is the primary driver. It penetrates deeper than UVB, reaches the melanocytes more effectively, and causes the oxidative damage that gradually alters their function. Importantly, UVA exposure happens even on overcast days, through car windows, and during incidental daily exposure that most people do not register as significant. The cumulative nature of the damage means that years of "I only get serious sun a few weeks a year" still adds up.
How they behave over time
The defining behavioural characteristic of sun spots is stability. Once formed, they do not change much on their own. They do not fade with time. They do not cycle with seasons the way melasma does. They do not resolve once a trigger is removed, because the trigger (cumulative UV damage) has already done its work at the cellular level.
Left alone, sun spots remain essentially the same indefinitely. They may darken slightly with additional UV exposure, and new spots can appear alongside existing ones, but established spots do not spontaneously lighten.
This stability is actually useful for identification. If a brown mark on your face has been exactly the same for months or years, not fading, not fluctuating, not changing with your cycle or the season, that behaviour is strongly suggestive of a sun spot rather than PIH (which fades) or melasma (which cycles).
It is also useful for setting treatment expectations. Because the melanocytes themselves are altered, treatment for sun spots is about removing or suppressing the existing pigment rather than waiting for the body's natural clearance process to handle it. The sun spot treatment guide and the sun spot timeline cover what realistic improvement looks like.
Ongoing sun protection does not reverse existing sun spots, but it slows the formation of new ones and prevents existing spots from darkening further. Protection is the long-term management layer, even after treatment.
How deep they typically sit
Sun spots are predominantly an epidermal condition. The melanocyte dysfunction is happening at the base of the epidermis, and the excess melanin is deposited in the upper skin layers. This is good news from a treatment perspective, because epidermal pigment is more accessible to both topical ingredients and professional procedures.
The colour of sun spots, typically a warm brown without blue-grey tones, reflects this epidermal location. Brown means the pigment is being viewed through the upper layers without the light-scattering effects that produce the muted, ashy appearance of dermal pigment.
That said, some older or more established sun spots may have a minor dermal component, particularly in people with significant cumulative UV damage. When this happens, treatment may produce significant improvement in the epidermal layer (the spot lightens noticeably) while a faint residual shadow persists from the deeper component.
Compared to melasma, which frequently involves mixed epidermal and dermal pigment, and PIH, which can range from purely epidermal to deeply dermal depending on the severity of the original inflammation, sun spots are the most consistently superficial of the three. This makes them generally more responsive to treatment, provided the right approach is used.
Relapse risk
The relapse profile of sun spots is straightforward: treated spots can recur if UV exposure continues, and new spots will continue to form in the same sun-exposed areas over time.
This is a different kind of relapse from melasma's hormonal cycling. Sun spot recurrence is dose-dependent. More cumulative UV exposure means more cellular damage means more spots. The melanocytes in treated areas remain susceptible to the same UV-driven damage that produced the original spot, so ongoing sun protection after treatment is not optional.
The practical implication: sun spot treatment works, and it tends to produce more predictable results than melasma treatment, but it is not a one-time fix. It is a periodic intervention combined with ongoing protection. Expecting to treat once and never deal with sun spots again is like expecting one dental cleaning to prevent all future cavities. The underlying process (UV damage, like plaque buildup) is continuous.
People who combine treatment with consistent broad-spectrum sun protection, including UVA coverage and attention to incidental daily exposure, experience significantly slower re-accumulation than those who treat and then return to previous habits.
How they are commonly confused
Sun spots vs PIH is the most common confusion on the face, because both present as brown marks that can appear in overlapping areas. The key differentiator is history and behaviour. PIH traces to a specific inflammatory event (a breakout, an injury, a procedure) and fades over time. Sun spots have no single triggering event and remain stable indefinitely. If you can identify when and why the mark appeared, it is more likely PIH. If it appeared gradually and has not changed, it is more likely a sun spot. The PIH vs Sun Spots comparison covers this in detail.
Sun spots vs melasma causes confusion because both appear on sun-exposed facial areas. The distinction is in the pattern: melasma is symmetrical and patch-like with diffuse edges. Sun spots are scattered, independent, and well-defined. Melasma fluctuates with hormones and seasons. Sun spots are stable. The triggers are different (hormonal signalling for melasma, cumulative UV for sun spots) and so are the treatment approaches. The Melasma vs Sun Spots comparison covers this.
Sun spots vs freckles is the most common confusion on lighter skin. Both are flat brown marks on sun-exposed areas, but freckles are smaller, more uniform, appear in childhood, and fluctuate with seasonal sun exposure (darkening in summer, fading in winter). Sun spots are larger, more irregular, develop later in life (typically 30s and beyond), and do not fluctuate. The Sun Spots vs Freckles comparison covers the distinction.
Sun spots vs seborrhoeic keratoses is worth knowing about even though seborrhoeic keratoses are not hyperpigmentation. These are benign growths that can appear brown and flat initially, making them easy to confuse with sun spots. As they develop, they become slightly raised and acquire a waxy or "stuck-on" texture. If a brown mark develops any elevation or textural change, it is worth having a dermatologist assess it.
When to see a dermatologist
Sun spots are benign, but the same UV exposure that causes them also increases the risk of other skin changes that look similar but carry different implications.
If a mark changes. Sun spots are stable. If a previously stable brown mark changes in size, shape, colour, border definition, or develops asymmetry, that is a reason to have it evaluated. Changes in a pre-existing mark can indicate a different process.
If a mark has an irregular border or multiple colours. Sun spots are generally uniform in colour within each spot and have relatively regular outlines. Marks with notched, scalloped, or highly irregular borders, or marks that contain multiple colours (brown, black, red, white, blue), warrant professional evaluation.
If a mark is raised or textured. Flat and smooth is the sun spot profile. Raised, scaly, rough, or crusty marks need assessment to distinguish between benign growths and precancerous lesions like actinic keratoses.
If you want to treat them. While topical approaches can lighten sun spots over time, the most effective treatments (targeted lasers, cryotherapy, certain professional peels) require clinical expertise and an accurate assessment of what is being treated. A dermatologist can confirm the diagnosis and recommend the most appropriate approach for your specific spots, skin tone, and goals.
For a baseline skin check. If you have multiple sun spots, you have had significant cumulative UV exposure. That exposure affects more than pigment. A full skin check establishes a baseline and catches anything that needs attention early.
Sun spots are not going anywhere on their own. That is not a reason to panic. It is a reason to stop waiting and start making a decision with accurate expectations about what treatment can and cannot do.
